WallStSmart

Coca-Cola European Partners PLC (CCEP)vsNatural Alternatives International (NAII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 15364% more annual revenue ($20.90B vs $135.16M). CCEP leads profitability with a 9.3% profit margin vs -9.1%. CCEP appears more attractively valued with a PEG of 2.78. CCEP earns a higher WallStSmart Score of 59/100 (C).

CCEP

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.55

NAII

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 2.0Value: 5.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPSignificantly Overvalued (-65.3%)

Margin of Safety

-65.3%

Fair Value

$59.08

Current Price

$95.10

$36.02 premium

UndervaluedFair: $59.08Overvalued
NAIIUndervalued (+89.9%)

Margin of Safety

+89.9%

Fair Value

$33.92

Current Price

$2.72

$31.20 discount

UndervaluedFair: $33.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

NAII2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
74.1%10/10

Earnings expanding 74.1% YoY

Areas to Watch

CCEP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Debt/EquityHealth
1.503/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NAII4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

Market CapQuality
$16.80M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.412/10

Expensive relative to growth rate

Return on EquityProfitability
-16.8%2/10

ROE of -16.8% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on EPS Growth, Return on Equity, Free Cash Flow.

Bull Case : NAII

The strongest argument for NAII centers on Price/Book, EPS Growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : NAII

The primary concerns for NAII are Revenue Growth, Market Cap, PEG Ratio.

Key Dynamics to Monitor

CCEP profiles as a value stock while NAII is a turnaround play — different risk/reward profiles.

CCEP carries more volatility with a beta of 0.51 — expect wider price swings.

NAII is growing revenue faster at 2.1% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (59/100 vs 46/100). NAII offers better value entry with a 89.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Natural Alternatives International

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Natural Alternatives International, Inc. is dedicated to formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company is headquartered in Carlsbad, California.

Want to dig deeper into these stocks?